Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trial
The DOI matches its Crossref record; 22 of the 24 references it cites were found in a registry or an index.
Abstract
Data are reported on electrocardiographic left ventricular hypertrophy (ECG LVH) among 8,012 men classified as hypertensive at baseline in the Multiple Risk Factor Intervention Trial. Compared with those allocated to the usual care (UC) control group, men allocated to the special intervention (SI) group experienced a mean reduction of 4 mm Hg in diastolic blood pressure and 7 mm Hg in systolic blood pressure, over 6 years of follow-up. There were 378 new cases of ECG LVH during follow-up; the incidence in the SI group was about 23% less than that in the UC group (4.2 vs 5.4% 2P less than 0.01). Among the 189 men with ECG LVH at baseline, those in the SI group experienced about 24% more annual follow-up visits at which they were free of ECG LVH (4.6 vs 3.7 visits; 2P less than 0.01). This reduced incidence and increased reversal of ECG LVH in the SI group compared with that in the UC group was consistent with significant overall reductions (2P less than 0.001) among SI men in mean wave amplitude in those leads in which voltage is correlated with left ventricular mass (T wave in V1, R wave in aVL and S wave in V3). In SI and UC groups combined, the presence of ECG LVH either at baseline or at follow-up was associated with several-fold increases in death from cardiovascular diseases in general, and death from coronary artery disease in particular.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MacMahon et al. (79) showed that even an 8-kg weight loss resulted in small but statistically greater reductions in LV wall thickness in mildly obese hypertensive patients compared with standard pharmacologic intervention.”
From Obesity and Cardiovascular Disease (2009) · cites this paper as [79]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,229
Covariance Analysis of Censored Survival Data
Breslow, N. (1974) · Biometrics · doi:10.2307/2529620 · Cited by 1,763
Multiple Risk Factor Intervention Trial: Risk Factor Changes and Mortality Results
(1982) · JAMA · doi:10.1001/jama.1982.03330120023025 · Cited by 1,722
Estimation of the probability of an event as a function of several independent variables
WALKER, S. H., & DUNCAN, D. B. (1967) · Biometrika · doi:10.1093/biomet/54.1-2.167 · Cited by 1,682
Casale, P. N., Devereux, R. B., Kligfield, P., Eisenberg, R. R., Miller, D. H., Chaudhary, B. S., & Phillips, M. C. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80115-7 · Cited by 581
Prevalence and natural history of electrocardiographic left ventricular hypertrophy
Kannel, W. B. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90111-0 · Cited by 404
The multiple risk factor intervention trial (MRFIT) II. The development of the protocol.
Sherwin, R., Kaelber, C., Kezdi, P., Kjelsberg, M. O., & Thomas, H. (1981) · Preventive Medicine · doi:10.1016/0091-7435(81)90058-x · Cited by 188
Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT)
The Multiple Risk Factor Intervention Trial Group (1977) · Journal of Chronic Diseases · doi:10.1016/0021-9681(77)90013-3 · Cited by 146
Research works printed but not linked: 1
- Fouad, 1987, Echocardiographic studies of regression of left ventricular hypertrophy, Hypertension, 65
Cited by
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Obesity and Cardiovascular Disease
Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.068 · Cited by 2,326
“MacMahon et al. ( 79 ) showed that even an 8-kg weight loss resulted in small but statistically greater reductions in LV wall thickness in mildly obese hypertensive patients compared with standard pharmacologic intervention.”
Background(1999) · Clinical and Experimental Hypertension · doi:10.3109/10641969909061028 · Cited by 1,209
Self-citationBlood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data
Stamler, J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410050036006 · Cited by 1,015
Self-citationNeaton, J. D. (1993) · JAMA · doi:10.1001/jama.270.6.713 · Cited by 946
Self-citation
Metadata
- Authors
- MacMahon, S., Collins, G., Rautaharju, P., Cutler, J., Neaton, J., Prineas, R., Crow, R., & Stamler, J.
- Affiliations
- Northwestern University (US)
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1989-01
- Volume
- 63
- Issue
- 3
- Pages
- 202-210
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2007722121
- Cited by
- 106
- References
- 24
- Citations by year
- 2023: 1 · 2022: 1 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 4 · 2014: 5 · 2013: 1 · 2012: 3
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Merck Sharp and Dohme
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- electrocardiographic left ventricular hypertrophy, hypertension, antihypertensive therapy, Multiple Risk Factor Intervention Trial, blood pressure reduction, left ventricular mass, cardiovascular mortality, coronary artery disease mortality, men
- MeSH terms
- Adult, Antihypertensive Agents, Blood Pressure, Electrocardiography, Follow-Up Studies, Cardiomegaly, Humans, Hypertension, Male, Middle Aged, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trial. https://app.cochat.ai/papers/10.1016/0002-9149(89)90286-5
- The paper
- MacMahon, S., Collins, G., Rautaharju, P., Cutler, J., Neaton, J., Prineas, R., Crow, R., & Stamler, J. (1989). Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trial. The American Journal of Cardiology. https://doi.org/10.1016/0002-9149(89)90286-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.